Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 10,000 shares at $75.74 ($777K) on 2017-03-27, disclosed to the SEC on 2017-03-28.
Open-market sale of $777k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.74 | 300 | $23K | 2.9% |
| 2 | $77.23 | 4,375 | $338K | 43.5% |
| 3 | $78.10 | 4,925 | $385K | 49.5% |
| 4 | $78.75 | 400 | $32K | 4.1% |
| Total | $77.67 avg | 10,000 | $777K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |